awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39895097-1765F5A6-CE7A-4DAC-9DA6-C5D2D5D13837
Q39895097-1765F5A6-CE7A-4DAC-9DA6-C5D2D5D13837
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39895097-1765F5A6-CE7A-4DAC-9DA6-C5D2D5D13837
New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability.
P2860
Q39895097-1765F5A6-CE7A-4DAC-9DA6-C5D2D5D13837
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39895097-1765F5A6-CE7A-4DAC-9DA6-C5D2D5D13837
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c3f640d7465fc7a320537eaafcee551bd12991a3
P2860
Should isoniazid be used in retreatment of tuberculosis despite acquired isoniazid resistance?